Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

When should a life sciences organization develop technology in-house? When is it more advantageous to purchase off-the-shelf solutions? And when is forming a strategic partnership the best course of action? These critical questions were addressed by Derk Arts, CEO of Castor, and Nick Darwall Smith during an insightful LinkedIn Live discussion. They delved into the true costs, potential risks, and various trade-offs associated with each approach to provide valuable insights for organizations navigating these complex decisions.

Read more about the recap and highlights of their discussion by accessing the full article.